Disseminated intravascular coagulation and associated factors in pediatric T-cell acute lymphoblastic leukemia
Main Article Content
Abstract
Disseminated intravascular coagulation (DIC) is a serious complication in patients with acute leukemia. This retrospective descriptive study analyzed medical records of 140 pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) diagnosed at the National Institute of Hematology and Blood Transfusion between 2019 and 2025, aiming to investigate the rate of DIC and associated factors. The results showed that males accounted for 76.4%, the median age was 10.2 years old, and 20.0% of patients expressed myeloid lineage-associated markers. The prevalence of DIC at initial assessment was 54.3%. Multivariable analysis identified two factors independently associated with DIC: white blood cell count ≥ 50 G/L (OR = 3.18; 95% CI: 1.41 – 7.17; p = 0.005) and absence of myeloid marker expression (OR = 2.55; 95% CI: 1.02 – 6.37; p = 0.044). These findings indicate that DIC is a common complication in pediatric patients with T-ALL. Therefore, coagulation testing should be performed immediately upon admission, particularly in patients with a white blood cell count ≥ 50 G/L and absence of myeloid immunophenotypic marker expression.
Article Details
Keywords
T-ALL, pediatric patients, disseminated intravascular coagulation, DIC, high white blood cell count
References
2. Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2016; 2016(1): 580-588.
3. ten Cate H. Management of disseminated intravascular coagulation in acute leukemia. Hämostaseologie. 2021; 41(2): 120-126.
4. Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation. Int J Hematol. 2014; 99(1): 15-23.
5. Songthawee N, Chavananon S, Sripornsawan P, et al. Prevalence and risk factors of disseminated intravascular coagulation in childhood acute lymphoblastic leukemia. Pediatr Res. 2023; 94(2): 588-593.
6. Al-Khalaila HF, Abbas MA, Almaharma MA. Disseminated Intravascular Coagulation in Pediatric Acute Leukemia: Prevalence, Laboratory Features, and Prognostic Significance of ISTH Score. Int J Lab Hematol. 2025.
7. Kittivisuit S, Jongthitinon N, Sripornsawan P, et al. Hyperleukocytosis in Childhood Acute Leukemia: Early Complications and Survival Outcomes. Cancers (Basel). 2023; 15(12): 3072.
8. WHO. Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th edition. Lyon: IARC; 2016.
9. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. 2001; 86(5): 1327-1330.
10. Trần Thị Kiều My, Nguyễn Thị Ánh, Nguyễn Khánh Hà. Rối loạn đông máu ở bệnh nhân đồng mắc ung thư tạng và bệnh máu ác tính. Tạp chí Y học Việt Nam. 2025; 551(3).
11. Akhter S, Karim MA, Ara UN, et al. Assessment of disseminated intravascular coagulation in children with acute lymphoblastic leukemia during induction chemotherapy in a tertiary care hospital. Mymensingh Med Journal. 2025; 34(4): 1133-1143. PMID: 41024552.